Literature DB >> 10881804

An experimental model of chronic myocardial hibernation.

J D St Louis1, G C Hughes, A P Kypson, T R DeGrado, C L Donovan, R E Coleman, B Yin, C Steenbergen, K P Landolfo, J E Lowe.   

Abstract

BACKGROUND: Hibernating myocardium describes persistently impaired ventricular function at rest caused by reduced coronary blood flow. However, a realistic animal model reproducing this chronic ischemic state does not exist. The purpose of this study was to explore whether chronic low-flow hibernation could be produced in swine.
METHODS: Miniswine underwent 90% stenosis of the left circumflex coronary artery. Positron emission tomography and dobutamine stress echocardiography were performed 3 and 30 days (n = 6) or 14 days (n = 4) after occlusion to evaluate myocardial blood flow and viability. Triphenyl tetrazolium chloride assessed percent infarction. Electron microscopy was used to identify cellular changes characteristic of hibernating myocardium.
RESULTS: Positron emission tomography (13N-labeled-ammonia) 3 days after occlusion demonstrated a significant reduction in myocardial blood flow in the left circumflex distribution. This reduced flow was accompanied by increased glucose use (18F-fluorodeoxyglucose), which is consistent with hibernating myocardium. Thirty days after occlusion, positron emission tomography demonstrated persistent low flow with increased glucose use in the left circumflex distribution. Dobutamine stress echocardiography 3 days after occlusion demonstrated severe hypocontractility at rest in the left circumflex region. Regional wall motion improved with low-dose dobutamine followed by deterioration at higher doses (biphasic response), findings consistent with hibernating myocardium. The results of dobutamine stress echocardiography were unchanged 30 days after occlusion. Triphenyl tetrazolium chloride staining (n = 6) revealed a mean of 8% +/- 2% infarction of the area-at-risk localized to the endocardial surface. Electron microscopy (n = 4) 14 days after occlusion demonstrated loss of contractile elements and large areas of glycogen accumulation within viable cardiomyocytes, also characteristic of hibernating myocardium.
CONCLUSIONS: Chronic low-flow myocardial hibernation can be reproduced in an animal model after partial coronary occlusion. This model may prove useful in the study of the mechanisms underlying hibernating myocardium and the use of therapies designed to improve blood flow to the heart.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881804     DOI: 10.1016/s0003-4975(00)01130-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

Review 2.  Myocardial hibernation in coronary artery disease.

Authors:  Dinesh K Kalra; William A Zoghbi
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

Review 3.  Modeling heart failure in animal models for novel drug discovery and development.

Authors:  Paul M L Janssen; Mohammad T Elnakish
Journal:  Expert Opin Drug Discov       Date:  2019-03-12       Impact factor: 6.098

4.  Closed-chest animal model of chronic coronary artery stenosis. Assessment with magnetic resonance imaging.

Authors:  Ming Wu; Jan Bogaert; Jan D'hooge; Karin Sipido; Frederik Maes; Steven Dymarkowski; Frank E Rademakers; Piet Claus
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-10       Impact factor: 2.357

Review 5.  Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications.

Authors:  William M Yarbrough; Francis G Spinale
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

6.  A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor.

Authors:  Karen J Keeran; Kenneth R Jeffries; Arthur D Zetts; Joni Taylor; Shawn Kozlov; Timothy J Hunt
Journal:  J Vis Exp       Date:  2017-10-09       Impact factor: 1.355

7.  Animal models of cardiac disease and stem cell therapy.

Authors:  Lailiang Ou; Wenzhong Li; Yi Liu; Yue Zhang; Shen Jie; Deling Kong; Gustav Steinhoff; Nan Ma
Journal:  Open Cardiovasc Med J       Date:  2010-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.